| Catalog Number |
405672 |
| Medical Device Problem Code |
Patient-Device Incompatibility (2682)
|
| Health Effect - Clinical Code |
No Known Impact Or Consequence To Patient (2692)
|
| Date of Event |
08/12/2019
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
|
| |
|
Event or Problem Description
|
|
Material no.(b)(4), batch no.0001276651.It was reported that during use of the tray spn whit25g3.5 l/b-d/e blue drape the drug is ineffective.The following information was provided by the initial reporter: the customer is reporting that the drug was not working at all on a patient.
|
| |
|
Additional Manufacturer Narrative
|
|
Investigation summary: a dhr review of all applicable manufacturing records for lot 0001276651 did not identify any issues that may have contributed to the reported failure mode.Failure mode could not be confirmed through sample analysis.All six (6) trays were opened and each drug vial was visually inspected for obvious defect.No defects were observed.Liquid within each vial was clear and without any visible particulate matter.The investigation was not able to identify or confirm any contribution to the reported failure mode from the factors noted above.Specific to the handling of the drugs, the investigation noted specific procedures to control the handling of any raw material drug component during the receipt, storage, and use in the manufacturing process.A review of the temperature monitoring system within the mannford facility did not identify any excursions that would have negatively affected any of the raw material drug components used within this product code.The investigation did identify this failure mode as a previously known issue.Conclusion(s): based on the complaint investigation, a probable root cause could not be identified for the reported failure mode.Bd has a long history of test results to support that drug potency issues have not been the cause of ineffective anesthesia events reported to bd through the complaint system.The investigation identified a previous capa (capa 67717) performed by the bd anesthesia quality group that specifically investigated the ¿ineffective anesthesia¿ failure mode.Likewise, the investigation identified a summary for previously investigated complaints which provides rationale and information regarding the potential ineffective anesthesia outcome during the use of an anesthesia product code.Based on a review of all of these sources, the current complaint investigation could not identify a definitive root cause nor could any potential contributor be identified for this specific complaint failure mode.
|
| |
|
Event or Problem Description
|
|
Material no.405672 batch no.0001276651.It was reported that during use of the tray spn whit25g3.5 l/b-d/e blue drape the drug is ineffective.The following information was provided by the initial reporter: the customer is reporting that the drug was not working at all on a patient.
|
| |
|
Search Alerts/Recalls
|